Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vladimir Tolmachev

Showing results (11-20 of 304) with videos related to

Pageof 31
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Methods for radiolabelling of monoclonal antibodiesVladimir Tolmachev, Anna Orlova, Karl Andersson
International Journal of Oncology|January 22, 2011
Imaging agents for in vivo molecular profiling of disseminated prostate cancer--targeting EGFR receptors in prostate cancer: comparison of cellular processing of [111In]-labeled affibody molecule Z(EGFR:2377) and cetuximabJennie Malmberg, Vladimir Tolmachev, Anna Orlova
Nuclear Medicine and Biology|July 9, 2010
Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteineSara Ahlgren, Kristofer Andersson, Vladimir Tolmachev
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclidesVladimir Tolmachev, Jörgen Carlsson, Hans Lundqvist
Applied Optics|October 8, 2003
Design criteria and optical characteristics of one-dimensional photonic crystals based on periodically grooved siliconVladimir Tolmachev, Tatiana Perova, Kevin Berwick
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicineMohamed Altai, Anna Orlova, Vladimir Tolmachev
Current Medicinal Chemistry|March 14, 2020
Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting PropertiesBogdan Mitran, Vladimir Tolmachev, Anna Orlova
Experimental and Therapeutic Medicine|September 15, 2012
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell linesJennie Malmberg, Vladimir Tolmachev, Anna Orlova
International Journal of Molecular Sciences|April 30, 2021
PET and SPECT Imaging of the EGFR Family (RTK Class I) in OncologySara S Rinne, Anna Orlova, Vladimir Tolmachev
The Lancet. Oncology|July 30, 2010
Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfallsVladimir Tolmachev, Sharon Stone-Elander, Anna Orlova
Pageof 31

Showing results (11-20 of 304) with videos related to

Sort By:
Pageof 31
Methods in Molecular Biology (Clifton, N.J.)|September 17, 2013
Methods for radiolabelling of monoclonal antibodiesVladimir Tolmachev, Anna Orlova, Karl Andersson
International Journal of Oncology|January 22, 2011
Imaging agents for in vivo molecular profiling of disseminated prostate cancer--targeting EGFR receptors in prostate cancer: comparison of cellular processing of [111In]-labeled affibody molecule Z(EGFR:2377) and cetuximabJennie Malmberg, Vladimir Tolmachev, Anna Orlova
Nuclear Medicine and Biology|July 9, 2010
Kit formulation for 99mTc-labeling of recombinant anti-HER2 Affibody molecules with a C-terminally engineered cysteineSara Ahlgren, Kristofer Andersson, Vladimir Tolmachev
Acta Oncologica (Stockholm, Sweden)|July 13, 2004
A limiting factor for the progress of radionuclide-based cancer diagnostics and therapy--availability of suitable radionuclidesVladimir Tolmachev, Jörgen Carlsson, Hans Lundqvist
Applied Optics|October 8, 2003
Design criteria and optical characteristics of one-dimensional photonic crystals based on periodically grooved siliconVladimir Tolmachev, Tatiana Perova, Kevin Berwick
Current Pharmaceutical Design|September 13, 2013
Radiolabeled probes targeting tyrosine-kinase receptors for personalized medicineMohamed Altai, Anna Orlova, Vladimir Tolmachev
Current Medicinal Chemistry|March 14, 2020
Radiolabeled GRPR Antagonists for Imaging of Disseminated Prostate Cancer - Influence of Labeling Chemistry on Targeting PropertiesBogdan Mitran, Vladimir Tolmachev, Anna Orlova
Experimental and Therapeutic Medicine|September 15, 2012
Imaging agents for in vivo molecular profiling of disseminated prostate cancer: Cellular processing of [(111)In]-labeled CHX-A″DTPA-trastuzumab and anti-HER2 ABY-025 Affibody in prostate cancer cell linesJennie Malmberg, Vladimir Tolmachev, Anna Orlova
International Journal of Molecular Sciences|April 30, 2021
PET and SPECT Imaging of the EGFR Family (RTK Class I) in OncologySara S Rinne, Anna Orlova, Vladimir Tolmachev
The Lancet. Oncology|July 30, 2010
Radiolabelled receptor-tyrosine-kinase targeting drugs for patient stratification and monitoring of therapy response: prospects and pitfallsVladimir Tolmachev, Sharon Stone-Elander, Anna Orlova
Pageof 31